Trials / Completed
CompletedNCT03387644
Pregabalin Premedication for Conscious Sedation
Pregabalin Premedication for Conscious Sedation for Flexible Bronchoscopy: A Randomized Double Blind Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Conscious sedation is usually required during flexible bronchoscopy. Sedation should be done without causing respiratory depression or loss of consciousness. The present study was designed to evaluate the advantage of pregabalin pre-medication on reducing sedatives and respiratory depression for patients undergoing flexible bronchoscopy with dexmedetomidine and midazolam.
Detailed description
Seventy patients undergoing elective flexible bronchoscopy were randomly divided into two equal groups, 35 patients each. All patients received premedication one hour before the procedure. PG group received 150 mg pregabalin and C group received placebo. All patients sedated to achieve optimum working conditions. Intra-operative respiratory rate and post procedure patients' and pulmonologists' satisfaction were compared in both groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin (PG) | Pregabalin 150 mg one hour before the procedure as premedication. |
| DRUG | Control placebo (C) | Placebo tablets one hour before the procedure as premedication. |
Timeline
- Start date
- 2015-04-15
- Primary completion
- 2016-11-24
- Completion
- 2017-05-16
- First posted
- 2018-01-02
- Last updated
- 2018-01-02
Source: ClinicalTrials.gov record NCT03387644. Inclusion in this directory is not an endorsement.